Ligand Pharmaceuticals Inc (LGND)

Depreciation & Amortization

$34.32M

TTM · Period ending: · USD

LGND logo

LGND Depreciation & Amortization

Latest reported$34.32M
LGND TTM Depreciation & Amortization ($2.50M → $34.32M)
High-resolution chart · PNG

LGND depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
34,324,000
34,631,000
35,185,000
34,188,000
34,913,000
35,244,000
35,239,000
36,042,000
35,659,000
36,301,000
37,103,000
37,743,000
42,637,000
47,793,000
53,360,000
52,927,000
52,035,000
49,676,000
47,635,000
50,814,000
42,749,000
34,679,000
27,966,000
37,186,000
41,182,000
43,833,000
42,539,000
23,800,000
20,664,000
16,802,000
14,718,000
15,554,000
12,163,000
11,737,000
11,714,000
10,549,000
11,466,000
11,694,000
11,290,000
9,009,000
6,719,000
4,552,000
2,627,000
2,599,000
2,616,000
2,639,000
2,657,000
2,654,000
2,661,000
2,661,000
2,663,000
2,756,000
2,726,000
2,719,000
2,727,000
2,669,000
2,781,000
2,904,000
2,790,000
2,194,000
2,113,000
2,031,000
2,212,000
1,381,000
2,669,000
2,898,000
3,134,000
4,108,000
3,399,000
2,226,000
1,052,000
1,178,000
329,000
1,508,000
2,615,000
4,939,000
8,709,000
12,404,000
16,217,000
18,306,000
18,884,000
18,975,000
18,707,000
17,875,000
16,998,000
15,923,000
15,275,000
14,912,000
14,573,000
14,464,000
14,280,000
16,054,000
14,296,000
12,475,000
10,472,000
6,447,000
6,384,000
6,500,000
6,573,000
-361,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.